Cargando…

Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression

BACKGROUND: Several publications have described differences in cross-sectional comparisons of gut microbiota between patients with Parkinson's disease and control subjects, with considerable variability of the reported differentially abundant taxa. The temporal stability of such microbiota alte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aho, Velma T.E., Pereira, Pedro A.B., Voutilainen, Sari, Paulin, Lars, Pekkonen, Eero, Auvinen, Petri, Scheperjans, Filip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606744/ https://www.ncbi.nlm.nih.gov/pubmed/31221587 http://dx.doi.org/10.1016/j.ebiom.2019.05.064

Ejemplares similares

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
por: Aho, Velma T. E., et al.
Publicado: (2021)

Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systematic Review
por: Boertien, Jeffrey M., et al.
Publicado: (2019)

Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease
por: Pereira, Pedro A. B., et al.
Publicado: (2022)

Gut microbiota composition is associated with narcolepsy type 1
por: Lecomte, Alexandre, et al.
Publicado: (2020)

Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia
por: Pereira, Pedro, et al.
Publicado: (2017)

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
por: Xie, Aoji, et al.
Publicado: (2022)

Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
por: Mertsalmi, Tuomas H., et al.
Publicado: (2021)

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
por: Boertien, Jeffrey M., et al.
Publicado: (2022)

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
por: van Kessel, Sebastiaan P., et al.
Publicado: (2021)

Motor outcome and electrode location in deep brain stimulation in Parkinson's disease
por: Koivu, Maija, et al.
Publicado: (2018)

Subgingival microbiota in a population with and without cognitive dysfunction
por: Holmer, Jacob, et al.
Publicado: (2021)

Real-Life Experience on Directional Deep Brain Stimulation in Patients with Advanced Parkinson’s Disease
por: Koivu, Maija, et al.
Publicado: (2022)

The Gut and Parkinson’s Disease: Hype or Hope?
por: Scheperjans, Filip, et al.
Publicado: (2018)

Deep brain stimulation for dystonia in Finland during 2007–2016
por: Ortiz, Rebekka M., et al.
Publicado: (2019)

The prevalence of adult-onset isolated dystonia in Finland 2007-2016
por: Ortiz, Rebekka, et al.
Publicado: (2018)

Comorbidity and retirement in cervical dystonia
por: Ortiz, Rebekka M., et al.
Publicado: (2019)

Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease
por: Murtomäki, Kirsi, et al.
Publicado: (2023)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson’s disease
por: Liikkanen, Sammeli, et al.
Publicado: (2023)

The microbiome of the human lower airways: a next generation sequencing perspective
por: Aho, Velma T. E., et al.
Publicado: (2015)

Gut microbiome alpha-diversity is not a marker of Parkinson’s disease and multiple sclerosis
por: Plassais, Jonathan, et al.
Publicado: (2021)

STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache
por: Huotarinen, Antti, et al.
Publicado: (2017)

Modulation of sensory cortical activity by deep brain stimulation in advanced Parkinson's disease
por: Korsun, Olesia, et al.
Publicado: (2022)

Gut microbiota: Implications in Parkinson's disease
por: Parashar, Arun, et al.
Publicado: (2017)

Deep brain stimulation for monogenic Parkinson’s disease: a systematic review
por: Kuusimäki, Tomi, et al.
Publicado: (2019)

Levodopa-Induced Changes in Electromyographic Patterns in Patients with Advanced Parkinson’s Disease
por: Ruonala, Verneri, et al.
Publicado: (2018)

Molecular analysis of meso- and thermophilic microbiota associated with anaerobic biowaste degradation
por: Ritari, Jarmo, et al.
Publicado: (2012)

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
por: Yang, Dongming, et al.
Publicado: (2019)

Gut, oral and nasal microbiota and Parkinson’s disease
por: Shen, Liang
Publicado: (2020)

Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
por: Yemula, Nehal, et al.
Publicado: (2021)

Problems related to levodopa‐carbidopa intestinal gel treatment in advanced Parkinson's disease
por: Udd, Marianne, et al.
Publicado: (2017)

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
por: Pauls, K. Amande M., et al.
Publicado: (2021)

Manifestations of Intellectual Disability, Dystonia, and Parkinson's Disease in an Adult Patient with ARX Gene Mutation c.558_560dup p.(Pro187dup)
por: Arvio, Maria, et al.
Publicado: (2023)

Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson’s disease
por: Schmit, Kristopher J., et al.
Publicado: (2023)

Changes in elbow flexion EMG morphology during adjustment of deep brain stimulator in advanced Parkinson’s disease
por: Ruonala, Verneri, et al.
Publicado: (2022)

Deep brain stimulation of subthalamic nucleus modulates cortical auditory processing in advanced Parkinson’s Disease
por: Valkonen, Kati, et al.
Publicado: (2022)

Application of hybridization control probe to increase accuracy on ligation detection or minisequencing diagnostic microarrays
por: Ritari, Jarmo, et al.
Publicado: (2009)

Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
por: Kang, Yongbo, et al.
Publicado: (2021)

Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
por: Vascellari, Sarah, et al.
Publicado: (2020)

Corrigendum: The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
por: Yang, Dongming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pqukher2i066lpqn2cgdnlniju